Lyophilized Sterile Vial
Tested: 99.6% (Selank) / 99.5% (Semax)
Current Lot: MV-2026-NRO20-01
Multi-Peptide Precision Synergy
Neuro-Focus Precision Blend (Selank + Semax)
20mg / 5mL (10mg Selank / 10mg Semax) • HPLC Purity: 99.6% (Selank) / 99.5% (Semax) • Target: ≥ 99.0% per component
Synergistic central nervous system peptide complex uniting GABA-modulating Selank with BDNF-inducing Semax for research into cognitive physiology and neuroprotection.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula Dual Nootropic Neuropeptide Matrix
Molecular Weight Co-Lyophilized Neuropeptide
CAS Registry # 129954-34-3 / 80714-61-0
Peptide Sequence / Structure Selank (10mg) + Semax (10mg)
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-NRO20-01 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| Selank HPLC Assay | 10.08 mg (99.6%) | RP-HPLC | Conforms |
| Semax HPLC Assay | 10.12 mg (99.5%) | RP-HPLC | Conforms |
| Endotoxin | < 0.02 EU/mg | USP <85> | Conforms |
Biological Mechanism of Action
Simultaneous enhancement of hippocampal BDNF expression (Semax) and allosteric GABA receptor modulation (Selank).
Research Focus Areas: Dual Neuro-Focus BDNF Induction GABAergic Balance
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for Selank / Semax Blend.